前列腺SBRT靶区运动缓解技术的重现性与准确性
本研究量化评估了在中间风险前列腺癌剂量递增5×9Gy SBRT研究中,采用直肠内气囊和带电磁信标的Foley导尿管进行靶区固定的准确性、重现性和前列腺运动缓解效果。结果显示该技术几何误差约1mm,所有治疗 session 均按计划完成剂量,支持使用2mm PTV外扩并实现正常组织剂量雕刻。
要点
- 直肠内气囊联合电磁信标Foley导尿管可有效缓解前列腺靶区运动。
- 总体系统性和随机性几何误差约为1mm,支持2mm PTV外扩。
- 7.4%的治疗 session 需暂时中断照射,6%需重新采集参考CBCT。
核心结论
- 该前列腺固定技术提供了极佳的准确性和重现性,支持在紧密PTV外扩下进行正常组织剂量雕刻。
研究设计与样本
- 前瞻性剂量递增5×9Gy SBRT研究中的技术评估,纳入189例患者共886次治疗 session,使用直肠内气囊和带三个电磁信标的Foley导尿管。
主要发现
- 平均PTV剂量为45.8±0.4 Gy(D95=40.5±0.4 Gy),平均需3.7±1.7次CBCT达到参考位置。
- 平均治疗时间19.5±12分钟,其中准备14.1±11分钟,治疗实施5.4±5.9分钟。
- 59%、30%和11%的 session 分别观察到0、1-2和>2 mm/10分钟的前列腺运动。
- 7.4%的 session 出现暂时中断照射,6%需重新参考CBCT纠正偏差,所有 session 均完成计划剂量。
- 准备时间>15分钟与需要第二次参考CBCT显著相关,总体系统性和随机性几何误差约为1mm。
关键数值与推荐
- 电磁信标检测到≥2mm/5秒的运动时,强制中断治疗并在完成计划剂量前重新对准靶区。
- PTV外扩为2mm,在与关键危及器官交界处缩减至0mm。
临床怎么用
- 该固定与监测技术可用于前列腺SBRT中实现紧密PTV外扩和正常组织剂量雕刻临床实践。
- 治疗准备时间超过15分钟时应警惕可能需要第二次参考CBCT,需优化流程效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To quantitate the accuracy, reproducibility and prostate motion mitigation efficacy rendered by a target immobilization method used in an intermediate-risk prostate cancer dose-escalated 5×9Gy SBRT study. MATERIAL AND METHODS: An air-inflated (150 cm3) endorectal balloon and Foley catheter with three electromagnetic beacon transponders (EBT) were used to mitigate and track intra-fractional target motion. A 2 mm margin was used for PTV expansion, reduced to 0 mm at the interface with critical OARs. EBT-detected ≥ 2 mm/5 s motions mandated treatment interruption and target realignment prior to completion of planned dose delivery. Geometrical uncertainties were measured with an in-house ESAPI script. RESULTS: Quantitative data were obtained in 886 sessions from 189 patients. Mean PTV dose was 45.8 ± 0.4 Gy (D95 = 40.5 ± 0.4 Gy). A mean of 3.7 ± 1.7 CBCTs were acquired to reach reference position. Mean treatment time was 19.5 ± 12 min, 14.1 ± 11 and 5.4 ± 5.9 min for preparation and treatment delivery, respectively. Target motion of 0, 1-2 and >2 mm/10 min were observed in 59%, 30% and 11% of sessions, respectively. Temporary beam-on hold occurred in 7.4% of sessions, while in 6% a new reference CBCT was required to correct deviations. Hence, all sessions were completed with application of the planned dose. Treatment preparation time > 15 min was significantly associated with the need of a second reference CBCT. Overall systematic and random geometrical errors were in the order of 1 mm. CONCLUSION: The prostate immobilization technique explored here affords excellent accuracy and reproducibility, enabling normal tissue dose sculpting with tight PTV margins.
引用
- Greco C, Stroom J, Vieira S, et al. Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy. Radiother Oncol. 2021. PMID: 33992627. doi:10.1016/j.radonc.2021.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。